JPMORGAN CHASE & CO - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 38 filers reported holding SCPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$139,545
-38.8%
19,599
-12.5%
0.00%
Q2 2023$228,164
+33.4%
22,391
+18.8%
0.00%
Q1 2023$171,000
+45258.1%
18,844
-64.2%
0.00%
Q4 2022$37752,582
+375485.7%
0.00%
Q4 2021$0
-100.0%
14
-99.6%
0.00%
Q2 2021$19,000
-85.0%
3,174
-83.3%
0.00%
Q1 2021$127,000
+28.3%
19,030
+1.4%
0.00%
Q4 2020$99,000
+153.8%
18,759
+268.4%
0.00%
Q3 2020$39,000
+200.0%
5,092
+181.6%
0.00%
Q2 2020$13,000
-95.7%
1,808
-95.6%
0.00%
Q1 2020$305,000
+38.6%
41,172
+6.0%
0.00%
Q4 2019$220,000
-21.7%
38,848
-18.2%
0.00%
Q3 2019$281,000
+5520.0%
47,489
+2632.4%
0.00%
Q1 2019$5,000
-28.6%
1,738
-6.6%
0.00%
Q4 2018$7,000
-94.7%
1,861
-91.8%
0.00%
Q3 2018$133,000
+1377.8%
22,664
+1268.6%
0.00%
Q2 2018$9,000
-50.0%
1,656
+11.6%
0.00%
Q1 2018$18,0001,4840.00%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 3,831,474$20,268,0006.83%
AIGH Capital Management LLC 637,322$3,372,0001.37%
Worth Venture Partners, LLC 162,875$862,0000.68%
Ikarian Capital, LLC 1,466,147$7,756,0000.34%
RA Capital Management 3,518,998$18,615,0000.26%
Orbimed Advisors 4,797,148$25,377,0000.22%
DAFNA Capital Management LLC 38,891$206,0000.06%
BOOTHBAY FUND MANAGEMENT, LLC 150,699$797,0000.03%
Alyeska Investment Group, L.P. 355,690$1,882,0000.03%
ALGERT GLOBAL LLC 13,860$73,0000.02%
View complete list of SCPHARMACEUTICALS INC shareholders